Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VIPR2 | P41587 | 5/20 | 0.59 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.59 |
| ▸ | GLP1R | P43220 | 4/20 | 0.59 |
| ▸ | ECE1 | P42892 | 1/20 | 0.59 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.58 |
| ▸ | NPY1R | P25929 | 2/20 | 0.58 |
| ▸ | NPY4R | P50391 | 2/20 | 0.58 |
| ▸ | GCGR | P47871 | 1/20 | 0.56 |
| ▸ | GIPR | P48546 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30176485 | 0.89 | VIPR2 (0.61) | VIPR2VIPR1GLP1RTFPINPY5R | |
| SCHEMBL31182584 | 0.88 | TFPI (0.66) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL30900770 | 0.88 | TFPI (0.66) | VIPR1GLP1RECE1MUS81TFPI | |
| SCHEMBL30607476 | 0.88 | TFPI (0.67) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL29797052 | 0.87 | MAPK8 (0.67) | TFPINPY5RNPY1RNPY4R | |
| SCHEMBL38664796 | 0.86 | VIPR1 (0.67) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL31683277 | 0.86 | VIPR2 (0.61) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL30567756 | 0.85 | VIPR1 (0.72) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL30495775 | 0.85 | VIPR1 (0.70) | VIPR2VIPR1GLP1RECE1MUS81 | |
| SCHEMBL29634728 | 0.85 | TFPI (0.61) | VIPR2VIPR1TFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259267-A9 | Inhibition Of TCR Signaling With Peptide Variants | SIGNABLOK, INC. | 2022-08-18 | — | — | US | claimed |